The next biotechnology/chemical/pharmaceutical
(BCP) customer partnership meeting will be held on September 2, 2009. The proposed agenda for that meeting is as follows:
Morning Session
• Greetings
and Overview (10:00 – 10:15 am EDT): John
LeGuyader, Remy
Yucel, and Michael
Wityshyn, Directors,
Technology Center 1600
• Interview
Practice (10:15
– 11:00 am): Tim
Callahan, Director, TC 2400
• Break (11:00
– 11:15 am)
• Reissue
Overview (11:15 am – 12:00 pm): Laufer
Pinchus, Office of Patent Legal Administration, and Jean
Vollano, QAS, TC 1600
• Inappropriate
Restricting (12:00 – 12:45 pm): Julie
Burke, QAS, TC 1600
• Lunch (12:45 – 2:00 pm)
Afternoon Session
• Pre-Appeal Conference — with demo (2:00 – 2:45 pm): Jean
Witz, Kathleen
Bragdon, and Bennett
Celsa, QASs, TC 1600
• Break (2:45 – 3:00 pm)
• Polymorphs
in Pharmaceutical Products (3:00 – 3:45 pm): Janet
Andres, SPE, Art Unit 1625
• Examining
Issue: Arrays
and Libraries (3:45 – 4:30 pm): Christopher
Low, SPE, Art
Unit 1636/1639
• Closing
Remarks/Discussion (4:30 – 4:45 pm): John
LeGuyader, Remy
Yucel, Michael
Wityshyn, Directors,
TC 1600
The presentation can be attended in person at the Madison
Auditorium, 600 Dulany Street, Alexandria, VA. The meeting can be viewed online here (select the "enter as guest" option). The Patent Office asks that non-USPTO employees login using their
e-mail addresses.

Leave a comment